Search

Saved articles

You have not yet added any article to your bookmarks!

Browse articles

New Cannabis-Derived Terpene Offers Hope for Chronic Pain Relief Without Opioids

Recent findings reveal that certain terpenes extracted from cannabis plants may offer an innovative way to alleviate chronic pain, potentially reducing the need for opioid medications.

Scientists at the University of Arizona Health Sciences have been investigating the pain-relieving properties of terpenes from Cannabis sativa that do not induce the psychoactive effects associated with THC.

Terpenes Emerging as a Novel Pain Management Strategy

Widely known for contributing to the aroma and taste of cannabis, terpenes are gaining attention for their promising therapeutic effects in pain reduction.

Add Cosmo Herald as a Preferred Source

In a report published in Pharmacological Reports, researchers evaluated four significant cannabis terpenes: geraniol, linalool, beta-caryophyllene, and alpha-humulene.

These compounds were assessed using mouse models simulating fibromyalgia and post-operative pain, with geraniol showing the most pronounced pain-suppressing capabilities.

Investigating Terpene Effects on Chronic Pain

This research extends previous work by Dr. John Streicher of the Comprehensive Center for Pain & Addiction, who noted terpenes were ineffective for acute pain but significantly helpful in treating chronic conditions.

The study demonstrated that terpene treatment effectively mitigated pain symptoms in chronic disorders such as fibromyalgia and post-surgical pain, both characterized by prolonged discomfort.

Fibromyalgia—a chronic musculoskeletal condition affecting up to 5% of people worldwide—has limited therapeutic options, making these discoveries particularly vital.

Additionally, while post-surgical pain usually resolves over time, it can cause lasting issues from inflammatory responses. Terpenes could become valuable alternatives to opioids in managing these complications.

scientists-discover-thc-free-cannabis-compound-that-could-end-chronic-pain-without-opioids-60bd24a0f924e863c9f61f68bbff5ef6.jpeg
Specific Cannabis sativa terpenes act as pain relievers in mouse studies by targeting adenosine A2a receptors.

The Future Beyond Opioid-Based Pain Treatments

A significant benefit of terpene-based therapies is their potential to replace opioids, especially for pain after surgery. Despite their effectiveness, opioids carry risks such as constipation and dependency.

Dr. Streicher highlighted that opioids manage acute post-surgery pain well but often lead to further complications. Terpenes may provide a safer, non-addictive alternative for managing such pain.

Worldwide, millions undergo surgery annually, with effective post-operative pain control crucial for recovery. As Dr. Streicher emphasized, “We are continually seeking improved options,” and terpenes could offer a promising path forward.

Harnessing Nature's Potential for Medical Advances

The work by Dr. Streicher’s team underscores the vast, unexplored potential within natural compounds. As Todd Vanderah, PhD, of the Comprehensive Center for Pain & Addiction, stated:

“Nature is incredible at making unique chemical structures, and many of these chemicals are unknowns when it comes to their abilities to aid in human health, diseases, and disorders.”

Terpenes exert their effects via the adenosine A2a receptor, the same pathway influenced by caffeine, which may explain their calming effects. This mechanism warrants further exploration for chronic pain treatments.

This research opens new avenues in natural medicine, encouraging the search for additional bioactive compounds that could meet unaddressed healthcare needs.

You might like:

0 comments

Sign in to Comment

Report Abuse

0 / 1000